» Articles » PMID: 35721857

Polyvinylpyrrolidone-Modified Taxifolin Liposomes Promote Liver Repair by Modulating Autophagy to Inhibit Activation of the TLR4/NF-κB Signaling Pathway

Overview
Date 2022 Jun 20
PMID 35721857
Authors
Affiliations
Soon will be listed here.
Abstract

Taxifolin (TAX) is a hepatoprotective flavanol compound, which is severely limited by poor solubility and low bioavailability. Liposomes (Lips) are used as well-recognized drug carrier systems that improve the water solubility and bioavailability of drugs, but are easily damaged by gastric juice after oral administration, resulting in the release of drugs in the gastric juice. Therefore, it is important to find materials that modify liposomes and avoid the destruction of the liposomal phospholipid bilayer structure by the gastrointestinal environment. Taxifolin liposomes (TAX-Lips) were modified by polyvinylpyrrolidone-k30 (PVP-TAX-Lips) and manufactured using a thin-film hydration technique. Particle size (109.27 ± 0.50 nm), zeta potential (-51.12 ± 3.79 mV), polydispersity coefficient (PDI) (0.189 ± 0.007), and EE (84.7 ± 0.2%) of PVP-TAX-Lips were studied. In addition, the results of release experiments indicated that the cumulative release rates of TAX-Lips and PVP-TAX-Lips were 89.73 ± 5.18% and 65.66 ± 4.86% in the simulated gastric fluid after 24 h, respectively, while the cumulative release rates were 68.20 ± 4.98% and 55.66 ± 3.92% in the simulated intestinal fluid after 24 h, respectively. Moreover, PVP-TAX-Lips were able to reverse lipopolysaccharide and D-galactosamine (LPS/D-GalN)-induced acute liver injury (ALI) by inducing autophagy to inhibit the expression levels of the TLR4/NF-κB signaling pathway and inflammatory factors, which suggested that PVP-TAX-Lips played an important role in the prevention of ALI and also provided a promising drug delivery system for the application of TAX.

Citing Articles

Synthesis of Taxifolin-Loaded Polydopamine for Chemo-Photothermal-Synergistic Therapy of Ovarian Cancer.

Lu Y, Liu X, Zhao T, Ding C, Ding Q, Wang N Molecules. 2024; 29(5).

PMID: 38474556 PMC: 10934848. DOI: 10.3390/molecules29051042.

References
1.
Zhou C, Guo C, Li W, Zhao J, Yang Q, Tan T . A novel honokiol liposome: formulation, pharmacokinetics, and antitumor studies. Drug Dev Ind Pharm. 2018; 44(12):2005-2012. DOI: 10.1080/03639045.2018.1506475. View

2.
Zu S, Yang L, Huang J, Ma C, Wang W, Zhao C . Micronization of taxifolin by supercritical antisolvent process and evaluation of radical scavenging activity. Int J Mol Sci. 2012; 13(7):8869-8881. PMC: 3430271. DOI: 10.3390/ijms13078869. View

3.
Rah S, Lee Y, Kim U . NAADP-mediated Ca signaling promotes autophagy and protects against LPS-induced liver injury. FASEB J. 2017; 31(7):3126-3137. PMC: 5471520. DOI: 10.1096/fj.201601290R. View

4.
Bunchorntavakul C, Reddy K . Acetaminophen (APAP or N-Acetyl-p-Aminophenol) and Acute Liver Failure. Clin Liver Dis. 2018; 22(2):325-346. DOI: 10.1016/j.cld.2018.01.007. View

5.
Edikresnha D, Suciati T, Munir M, Khairurrijal K . Polyvinylpyrrolidone/cellulose acetate electrospun composite nanofibres loaded by glycerine and garlic extract with antibacterial activity and release behaviour test. RSC Adv. 2022; 9(45):26351-26363. PMC: 9070455. DOI: 10.1039/c9ra04072b. View